Genetics of hereditary colon cancer - A basis for prevention?

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1215-1223

  Muller H Hj ^a   Heinimann, K ^a   Dobbie, Z ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Colon cancer prevention; Familial adenomatous polyposis; Hamartoma polyposis syndromes; Hereditary non polyposis colorectal cancer

Indexed keywords

CANCER GENETICS; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONFERENCE PAPER; CONGENITAL TUMOR; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; GENOTYPE; HUMAN; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MUTATION; PEDIGREE; PHENOTYPE; RISK FACTORS;

EID: 0343497012     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00111-8     Document Type: Conference Paper

References (88)

1. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997, 275, 1943-1947.
2. Marsh DJ, Coulon V, Lunetta KL, et al. Mutation spectrum and genotype-phenotype analysis in Cowden disease and BannayanZonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998, 7, 507-515.
3. Olschwang S, Serova-Sinilnikova OM, Lenoir GM, Thomas G. PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998, 18, 12-14.
4. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/ DPC4 gene in juvenile polyposis. Science 1998, 280, 1086-1088.
5. Laugier P, Hinziker N. Pigmentation mélanique lenticulaire essentielle de la muqueuse jugal et des lèvres. Arch Belg Dermatol Syphilol 1970, 26, 391-399.
6. Jenne DE, Reimann N, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine theronine kinase. Nat Genet 1998, 18, 38-413.
7. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391, 184-187.
8. Ilyas M, Straub J, Tomlinson IPM, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer 1999, 35, 335-351.
9. Wu TT, Rezai B, Rashid A. Genetid alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am Journal Pathol 1997, 150, 939-947.
10. Huang J, Papadopoulos N, McKinley AJ, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 1996, 93, 9049-9054.
11. Miyaki M, lijima T, Kimura J, et al. Frequent mutation of betacatenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 1999, 59, 4506-4509.
12. Duval A, lacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamelin R. Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene 1999, 18, 6806-6809.
13. Ponz de Leon M, Benatti P, Percesepe A, et al. Clinical features and genotype-phenotype correlations in 41 Italian families with adenomatosis coli. Ital J Gastroenterol Hepatol 1999, 31, 850-860.
14. Heinimann K, Mullhaupt B, Weber W, et al. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 1998, 43, 675-679.
15. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998, 85, 742-750.
16. Hofgartner WT, Thorp M, Ramus MW, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999, 94, 2275-2281.
17. Heiskanen I, Kellokumpu I, Jarvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999, 31, 412-416.
18. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992, 102, 1980-1982.
19. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 1993, 2, 425-134.
20. Ficari F, Cama A, Valanzano R, et al. APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. BY J Cancer 2000, 82, 348-353.
21. Caspari R, Friedl W, Mandl M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer (erratum appears in Lancet 1994, 343, 863). Lancet 1994, 343, 629-632.
22. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993, 75, 951-957.
23. Leggett BA, Young JP, Biden K, Buttenshaw RL, Knight N, Cowen AE. Severe upper gastrointestinal polyposis associated with sparse colonie polyposis in a familial adenomatous polyposis family with an APC mutation at codon 1520. Gut 1997, 41, SIS-521.
24. Scott RJ, van der Luijt R, Spycher M, et al. Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut 1996, 38, 794.
25. van der Luijt RB, Meera Khan P, Vasen HF, et al. Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 1996, 98, 727-734.
26. Friedl W, Meuschel S, Caspari R, et al. Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 1996, 97, 579-584.
27. Gismondi V, Stagnaro P, Pedemonte S, et al. Chain-terminating mutations in the APC gene lead to alterations in APC RNA and protein concentration. Genes Chromosomes Cancer 1998, 22, 278286.
28. Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993, 90, 2846-2850.
29. Young J, Simms LA, Tarish J, et al. A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9. Hum Mutat 1998, 11, 450-455.
30. Rozen P, Samuel Z, Shomrat R, Legum C. Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9. Gut 1999, 45, 829-833.
31. Curia MC, Esposito DL, Aceto G, et al. Transcript dosage effect in familial adenomatous polyposis: model offered by two kindreds with exon 9 APC gene mutations. Hum Mutat 1998, 11, 197-201.
32. Samowitz WS, Thliveris A, Spirio LN, White R. Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Cancer Res 1995, 55, 3732-3734.
33. van der Luijt RB, Vasen HF, Tops CM, Breukel C, Fodde R, Meera Khan P. APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum Genet 1995, 96, 705-710.
34. Scott RJ, Taeschner W, Heinimann K, et al. Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred. Eur J Hum Genet 1997, 5, 43-49.
35. Smits R, Kielman MF, Breukel C, et al. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 1999, 13, 1309-1321.
36. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA 1998, 95, 10722-10727.
37. Pedemonte S, Sciallero S, Gismondi V, et al. Novel germline APC variants in patients with multiple adenomas. Genes Chromosomes Cancer 1998, 22, 257-267.
38. Lamlum H, Papadopoulou A, Ilyas M, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000, 97, 2225-2228.
39. White RL. Colon polyps: a damaged developmental system and a precursor to cancer. Cytogenet Cell Genet 1999, 86, 95-98.
40. Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 1999, 5, 1071-1075.
41. Spirio LN, Samowitz W, Robertson J, et al. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 1998, 20, 385-388.
42. Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995, 81, 197-205.
43. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. The secretory phospholipase A2 gene is a candidate for the Moml locus, a major modifier of ApcMininduced intestinal neoplasia. Cell 1995, 81, 957-966.
44. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Ape delta? 16 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87, 803-809.
45. Giarola M, Stagi L, Presciuttini S, et al. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 1999, 13, 116-123.
46. Laken SJ, Papadopoulos N, Petersen GM, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 1999, 96, 2322-2326.
47. Tops CM, van der Klift HM, van der Luijt RB, et al. Non-allelic heterogeneity of familial adenomatous polyposis. Am J Med Genet 1993, 47, 563-567.
48. Stella A, Resta N, Gentile M, et al. Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 1993, 53, 1031-1037.
49. Dobbie Z, Muller HJ. Germline mutations in thé beta-catenin gene are not associated with the FAP phenotype without an APC mutation. J Med Genet 1999, 36, 573-574.
50. Cao X, Eu KW, Seow-Choen F, Cheah PY. Germline mutations are frequent in the APC gene but absent in the beta-catenin gene in familial adenomatous polyposis patients. Genes Chromosomes Cancer 1999, 25, 396-398.
51. da Costa LT, He TC, Yu J, et al. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene 1999, 18, 5010-5014.
52. Wicking C, Simms LA, Evans T, et al. CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer. Oncogene 1998, 17, 657-659.
53. Roose J, Huls G, van Beest MP, et al. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcfl. Science 1999, 285, 1923-1926.
54. Baulida J, Batlle E, Garcia De Herreros A. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/ Tcf-4 mediated transcription in intestinal cells. Biochem J 1999, 344, 565-570.
55. Aaltonen LA. Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. Recent Results Cancer Res 1998, 154, 306-311.
56. Lynch HT, de la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet 1999, 36, 801-818.
57. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995, 64, 430-433.
58. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996, 110, 1020-1027.
59. Aarnio M, Mustonen H, Mecklin JP, Jarvinen HJ. Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med 1998, 30, 75-80.
60. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993, 75, 1227-1236.
61. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260, 816-819.
62. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997, 386, 761-763.
63. Jiricny J. Replication errors: cha(lle)nging the genome. EMBO J 1998, 17, 6427-6436.
64. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999, 9, 89-96.
65. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998, 2, 67-71.
66. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994, 371, 75-80.
67. Palombo F, Gallinari P, laccarino I, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995, 268, 1912-1914.
68. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996, 2, 169-174.
69. Wijnen J, de Leeuw W, Vasen H, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nature Genet 1999, 23, 142-144.
70. Kolodner RD, Tytell JD, Schmeits JL, et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res 1999, 59, 5068-5074.
71. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116, 1453-1456.
72. Yan H, Papadopoulos N, Marra G, et al. Conversion of diploidy to haploidy. Nature 2000, 403, 723-724.
73. Tomlinson I, Rahman N, Fryling I, et al. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology 1999, 116, 789-795.
74. Lu SL, Kawabata M, Imamura T, et al. HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nature Genet 1998, 19, 17-18.
75. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66, 1191-1308.
76. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995, 25, 27-65.
77. Houlston RS, Tomlinson IP. Modifier genes in humans: strategies for identification. Eur J Hum Genet 1998, 6, 80-88.
78. Risch A, Wallace DM, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995, 4, 231-236.
79. Moisio AL, Sistonen P, Mecklin JP, Jarvinen H, Peltomaki P. Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer. Gastroenterology 1998, 115, 1387-1394.
80. Heinimann K, Scott RJ, Chappuis P, et al. N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res 1999, 59, 3038-3040.
81. Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994, 369, 154-156.
82. Ilett KF, Reeves PT, Minchin RF, Kinnear BF, Watson HF, Kadlubar FF. Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Cardnogenesis 1991, 12, 1465-1469.
83. Hubbard AL, Harrison DJ, Moyes C, et al. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 1997, 41, 229-234.
84. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
85. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. TiBS 1999, 9, M57-M60.
86. Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 1998, 95, 11301-11306.
87. Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 1999, 5, 1071-1075.
88. Fleck O, Lehmann E, Schar P, Kohli J. Involvement of nucleotideexcision repair in msh2 pms1-independent mismatch repair. Nat Gent 1999, 21, 314-317.